Evolution of Clinical Proteomics and its Role in Medicine

被引：46

作者：

Boja, Emily ^{[1
]}

Hiltke, Tara ^{[1
]}

Rivers, Robert ^{[1
]}

Kinsinger, Christopher ^{[1
]}

Rahbar, Amir ^{[1
]}

Mesri, Mehdi ^{[1
]}

Rodriguez, Henry ^{[1
]}

机构：

[1] NCI, Off Canc Clin Prote Res, Ctr Strateg Sci Initiat, NIH, Bethesda, MD 20892 USA

来源：

JOURNAL OF PROTEOME RESEARCH | 2011年 / 10卷 / 01期

关键词：

biomarker; clinical proteomics; protein quantitation; post-translational modifications; multiple reaction monitoring mass spectrometry; enzyme-linked immunosorbent assay; immunohistochemistry; flow cytometry; nanotechnology; verification; qualification; genomics; The Cancer Genome Atlas; TANDEM MASS-SPECTROMETRY; CODED AFFINITY TAGS; ISOBARIC TAGGING REAGENTS; COMPLEX PROTEIN MIXTURES; LABEL-FREE; QUANTITATIVE PROTEOMICS; BIOMARKER DISCOVERY; ABSOLUTE QUANTIFICATION; 2-DIMENSIONAL ELECTROPHORESIS; PEPTIDE IDENTIFICATION;

D O I：

10.1021/pr100532g

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Significant progress has been made in characterizing and sequencing genomic alterations of biospecimens from several types of cancer. Understanding the functional changes in the human proteome that arise from the genomic alterations or other factors is the next logical step in the development of high-value protein biomarkers that can be transitioned to clinical studies for biomarker qualification. Linking advances in genomic analysis to proteomic analysis will provide a pathway for qualified biomarkers which can drive the rational development of new diagnostics and therapies. The availability of these multidimensional data to the scientific community sets the stage for the development of new molecularly targeted cancer interventions.

引用

页码：66 / 84

页数：19

共 50 条

[41] The role of laughter in traditional medicine and its relevance to the clinical setting: Healing with ha!
Balick, MJ
Lee, R
ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2003, 9 (04) : 88 - 91
[42] The Increasing Role of Mass Spectrometry in Quantitative Clinical Proteomics
Whiteaker, Jeffrey R.
CLINICAL CHEMISTRY, 2010, 56 (09) : 1373 - 1374
[43] Signal Processing in Genomics and Proteomics: Defining Its Role
Dimitrova, Nevenka
Klein-Seetharaman, Judith
Beyerlein, Peter
Tewfik, Ahmed H.
IEEE SIGNAL PROCESSING MAGAZINE, 2012, 29 (01) : 19 - 21
[44] Molecular nuclear medicine. The challenge of genomic and proteomics to clinical practice
European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 (5) : 752 - 752
[45] The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma
Alaaeddine, Rana
Fayad, Mira
Nehme, Eliana
Bahmad, Hisham F.
Kobeissy, Firas
PERSONALISED MEDICINE: LESSONS FROM NEURODEGENERATION TO CANCER, 2017, 1007 : 59 - 70
[46] Clinical Proteomics in Colorectal Cancer, a Promising Tool for Improving Personalised Medicine
Chauvin, Anais
Boisvert, Francois-Michel
PROTEOMES, 2018, 6 (04)
[47] Proteomics in transfusion medicine
Reddy, KS
Perrotta, PL
TRANSFUSION, 2004, 44 (04) : 601 - 604
[48] Proteomics and transfusion medicine
Lion, N.
Prudent, M.
Crettaz, D.
Tissot, J. -D.
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2011, 18 (02) : 79 - 96
[49] Proteomics and Precision Medicine
Ding, Chen
Qin, Zhaoyu
Li, Yon
Shi, Wenhao
Li, Lingling
Zhan, Dongdong
Yang, Wenjun
SMALL METHODS, 2019, 3 (07):
[50] Bacterial proteomics and its role in antibacterial drug discovery
Brötz-Oesterhelt, H
Bandow, JE
Labischinski, H
MASS SPECTROMETRY REVIEWS, 2005, 24 (04) : 549 - 565

← 1 2 3 4 5 →